Vivos Therapeutics, Inc. (VVOS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 20.86M |
| Enterprise Value | 32.33M |
| P/E Ratio | -0.19 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.13 |
| Price/Book Ratio | -5.56 |
| Enterprise/Revenue | 0.65 |
| Enterprise/EBITDA | -0.54 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -1.28 |
| Operating Margin | -1.15 |
| Return On Assets | -1 |
| Return On Equity | -22.39 |
| Revenue | 17.44M |
| Revenue/Share | 1.34 |
| Gross Profit | 10.54M |
| EBITDA | -19.92M |
| Net Income | -21.23M |
| Diluted EPS | -2.06 |
| Total Cash | 2.11M |
| Total Cash/Share | 0.14 |
| Total Debt | 12.27M |
| Total Debt/Equity | -10.78 |
| Current Ratio | 0.27 |
| Book Value Per Share | -0.09 |
| 52-Week Change | -93.78 |
| 52-Week High | 7.4 |
| 52-Week Low | 0.38 |
| Moving Average 50 Days | 0.61 |
| Moving Average 200 Days | 1.64 |
| Average Volume | 1.71M |
| Shares Outstanding | 5.89M |
| % Held by Institutions | 16.62 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | October 27, 2023 |